GlassScriptPhysician profile
Christopher W Baugh
NPI 1629198189
$146,165.02
in general payments reported to CMS, 2019-2025
17 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $15K · 2021: $4,975 · 2022: $41K · 2023: $16K · 2024: $44K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,716 · Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,077.75 |
| Travel and Lodging | $17,078.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,716.00 |
| Food and Beverage | $1,951.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics International LTD | $54,395.94 | 2021-2025 | |
| Roche Diagnostics Corporation | $29,862.66 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $13,425.82 | 2022-2023 | Andexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12,109.47 | 2019-2023 | Xifaxan, Relistor |
| Pfizer INC. | $11,598.72 | 2023-2024 | |
| Btg International INC. | $5,621.11 | 2025 | Aurlumyn |
| Ultrasight INC | $5,298.43 | 2024 | Ultrasight Ai Guidance |
| Vapotherm INC | $3,601.05 | 2019 | |
| Terumo Medical Corporation | $3,300.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $2,731.25 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2020 | |
| Astrazeneca Uk Limited | $980.00 | 2024 | |
| Visby Medical, INC. | $800.00 | 2023 | Visby Medical Sexual Health Click Test |
| Rivanna Medical, INC | $300.00 | 2023 | Accuro |
| Janssen Pharmaceuticals, INC | $124.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.19 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Baugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.